Prescription drug · ANDA
Deflazacort NDC 70710-2053
Deflazacort 30 mg/1 · Tablet · Oral · Zydus Pharmaceuticals (USA) Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-2053-3 | 70710205303 | 1 BOTTLE in 1 CARTON (70710-2053-3) / 30 TABLET in 1 BOTTLEMarketed from Jun 12, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Deflazacort
- Generic name (nonproprietary)
- deflazacort
- Active ingredients
- Deflazacort — 30 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219254
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 70710-2053_117ea1b8-4f49-41cc-a1fe-3b18af2cb4d8SPL ID 117ea1b8-4f49-41cc-a1fe-3b18af2cb4d8SPL set ID f99fde7c-91ac-4d67-bd76-2b18a1d31f7dRxCUI 153098, 153880, 1870954, 1870958UNII KR5YZ6AE4BUPC 0370710205331
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470710205303followed by a unit qualifier and the quantityPackage 70710-2053-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. Deflazacort tablets are a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 219254
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Deflazacort | Deflazacort 30 mg/1 | TabletOral | AvKARE | 73190-070 |
| Deflazacort | Deflazacort 6 mg/1 | TabletOral | AvKARE | 73190-068 |
| Deflazacort | Deflazacort 18 mg/1 | TabletOral | AvKARE | 73190-069 |
| Deflazacort | Deflazacort 36 mg/1 | TabletOral | AvKARE | 73190-071 |
| Jaytharideflazacort | Deflazacort 18 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-175 |
| Deflazacort | Deflazacort 6 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2051 |
| Jaytharideflazacort | Deflazacort 6 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-174 |
| Jaytharideflazacort | Deflazacort 30 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-176 |
| Deflazacort | Deflazacort 18 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2052 |
| Jaytharideflazacort | Deflazacort 36 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-177 |
| Deflazacort | Deflazacort 36 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2054 |
| Deflazacort | Deflazacort 36 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-208 |
| Deflazacort | Deflazacort 6 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-204 |
| Deflazacort | Deflazacort 18 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-206 |
| Deflazacort | Deflazacort 30 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-207 |
| Jaytharideflazacort | Deflazacort 36 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1752 |
| Jaytharideflazacort | Deflazacort 6 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1749 |
| Jaytharideflazacort | Deflazacort 18 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1750 |
| Jaytharideflazacort | Deflazacort 30 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1751 |